197 related articles for article (PubMed ID: 36967045)
1. Chemotherapy and female fertility.
Sellami I; Beau I; Sonigo C
Ann Endocrinol (Paris); 2023 May; 84(3):382-387. PubMed ID: 36967045
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Chemotherapy on the Ovaries: Molecular Aspects and the Prevention of Ovarian Damage.
Sonigo C; Beau I; Binart N; Grynberg M
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31717833
[TBL] [Abstract][Full Text] [Related]
3. Ovarian damage from chemotherapy and current approaches to its protection.
Spears N; Lopes F; Stefansdottir A; Rossi V; De Felici M; Anderson RA; Klinger FG
Hum Reprod Update; 2019 Nov; 25(6):673-693. PubMed ID: 31600388
[TBL] [Abstract][Full Text] [Related]
4. [Fertility preservation strategies in young women in case of breast cancer or hematologic malignancy].
Decanter C; Robin G
Gynecol Obstet Fertil; 2013 Oct; 41(10):597-600. PubMed ID: 24094596
[TBL] [Abstract][Full Text] [Related]
5. [Oncofertility and breast cancer].
Sonigo C; Grynberg M; Bringer S; Sermondade N
Bull Cancer; 2019 Dec; 106(12S1):S43-S52. PubMed ID: 32008738
[TBL] [Abstract][Full Text] [Related]
6. The PARP inhibitor, olaparib, depletes the ovarian reserve in mice: implications for fertility preservation.
Winship AL; Griffiths M; Lliberos Requesens C; Sarma U; Phillips KA; Hutt KJ
Hum Reprod; 2020 Aug; 35(8):1864-1874. PubMed ID: 32604417
[TBL] [Abstract][Full Text] [Related]
7. Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency.
Suzuki N; Yoshioka N; Takae S; Sugishita Y; Tamura M; Hashimoto S; Morimoto Y; Kawamura K
Hum Reprod; 2015 Mar; 30(3):608-15. PubMed ID: 25567618
[TBL] [Abstract][Full Text] [Related]
8. Impact of first-line cancer treatment on the follicle quality in cryopreserved ovarian samples from girls and young women.
Pampanini V; Wagner M; Asadi-Azarbaijani B; Oskam IC; Sheikhi M; Sjödin MOD; Lindberg J; Hovatta O; Sahlin L; Björvang RD; Otala M; Damdimopoulou P; Jahnukainen K
Hum Reprod; 2019 Sep; 34(9):1674-1685. PubMed ID: 31411325
[TBL] [Abstract][Full Text] [Related]
9. The cyto-protective effects of LH on ovarian reserve and female fertility during exposure to gonadotoxic alkylating agents in an adult mouse model.
Del Castillo LM; Buigues A; Rossi V; Soriano MJ; Martinez J; De Felici M; Lamsira HK; Di Rella F; Klinger FG; Pellicer A; Herraiz S
Hum Reprod; 2021 Aug; 36(9):2514-2528. PubMed ID: 34333622
[TBL] [Abstract][Full Text] [Related]
10. Prevention of chemotherapy-induced ovarian damage: possible roles for hormonal and non-hormonal attenuating agents.
Roness H; Kalich-Philosoph L; Meirow D
Hum Reprod Update; 2014; 20(5):759-74. PubMed ID: 24833728
[TBL] [Abstract][Full Text] [Related]
11. [Systematic proposal of fertility preservation by mature oocyte cryopreservation for recurrent benign ovarian tumors].
Dadoun Y; Azaïs H; Keller L; d'Orazio E; Collinet P; Decanter C
Gynecol Obstet Fertil Senol; 2017 Jun; 45(6):359-365. PubMed ID: 28506797
[TBL] [Abstract][Full Text] [Related]
12. Female fertility preservation: past, present and future.
Fisch B; Abir R
Reproduction; 2018 Jul; 156(1):F11-F27. PubMed ID: 29581237
[TBL] [Abstract][Full Text] [Related]
13. Advances in the Treatment and Prevention of Chemotherapy-Induced Ovarian Toxicity.
Cho HW; Lee S; Min KJ; Hong JH; Song JY; Lee JK; Lee NW; Kim T
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096794
[TBL] [Abstract][Full Text] [Related]
14. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.
Abir R; Ben-Aharon I; Garor R; Yaniv I; Ash S; Stemmer SM; Ben-Haroush A; Freud E; Kravarusic D; Sapir O; Fisch B
Hum Reprod; 2016 Apr; 31(4):750-62. PubMed ID: 26848188
[TBL] [Abstract][Full Text] [Related]
15. Fertility Preservation: The Challenge of Freezing and Transplanting Ovarian Tissue.
Dolmans MM; Donnez J; Cacciottola L
Trends Mol Med; 2021 Aug; 27(8):777-791. PubMed ID: 33309205
[TBL] [Abstract][Full Text] [Related]
16. Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure.
Pascuali N; Scotti L; Di Pietro M; Oubiña G; Bas D; May M; Gómez Muñoz A; Cuasnicú PS; Cohen DJ; Tesone M; Abramovich D; Parborell F
Hum Reprod; 2018 May; 33(5):844-859. PubMed ID: 29534229
[TBL] [Abstract][Full Text] [Related]
17. Cryopreservation of female reproductive potential.
Gook DA; Edgar DH
Best Pract Res Clin Obstet Gynaecol; 2019 Feb; 55():23-36. PubMed ID: 30249473
[TBL] [Abstract][Full Text] [Related]
18. Cryopreservation of Oocytes Retrieved from Ovarian Tissue to Optimize Fertility Preservation in Prepubertal Girls and Women.
Brouillet S; Ferrieres-Hoa A; Fournier A; Martinez G; Bessonnat J; Gueniffey A; Gala A; Loup V; Hamamah S
J Vis Exp; 2020 Oct; (164):. PubMed ID: 33165323
[TBL] [Abstract][Full Text] [Related]
19. Serum antimüllerian hormone is associated with the number of oocytes matured in vitro and with primordial follicle density in candidates for fertility preservation.
Sermondade N; Sonigo C; Sifer C; Valtat S; Ziol M; Eustache F; Grynberg M
Fertil Steril; 2019 Feb; 111(2):357-362. PubMed ID: 30527837
[TBL] [Abstract][Full Text] [Related]
20. [Fertility preservation in women of the childbearing age: Indications and strategies].
Bénard J; Calvo J; Comtet M; Benoit A; Sifer C; Grynberg M
J Gynecol Obstet Biol Reprod (Paris); 2016 May; 45(5):424-44. PubMed ID: 27021926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]